Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Efficacy Study of Pyrimethamine / Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

NCT00951106 is registered in ClinicalTrials.gov with Walter Reed Army Institute of Research (WRAIR) as lead sponsor.

NCT NCT00951106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00951106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Efficacy Study of Pyrimethamine / Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon
Lead sponsor
Walter Reed Army Institute of Research (WRAIR)
Phase
Not applicable
Overall status
Completed
Start date
January 31, 1998
Completion date
August 31, 2009
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, falciparum, malaria, vivax